PATENT CLAIM ANALYSIS

Application Number: 15984926
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["607", "040000"]

Abstract:
Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.

Claim (Index 16):
The method of  claim 15 , wherein the agent increases the amount of insulin and/or increases the sensitivity of cells to insulin.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 93.0
- Lexical Diversity: 2.02857
- Patent Class: 607.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13681581', '12417918', '15098704', '14814094', '12537019']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7033547217107161
- 35 USC 102 Novelty (BERT): 0.5406586140333934
- Combined Prediction Score: 0.6870851109429839
- Mean Citation Score: 352.33995000000016
- Max Citation Score: 420.82147
- Similarity Product: 284.3075337053674

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test